Skip to main content
Teva Pharmaceutical Industries Limited (TLV:TEVA)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
10,610
+60 (0.57%)
At close: Feb 27, 2026

TLV:TEVA Revenue

In the year 2025, Teva Pharmaceutical Industries had annual revenue of $17.26B USD with 4.32% growth. Teva Pharmaceutical Industries had revenue of $4.71B in the quarter ending December 31, 2025, with 11.40% growth.

Revenue
$17.26B
Revenue Growth
+4.32%
P/S Ratio
2.25
Revenue / Employee
$525.49K
Employees
32,842
Market Cap
123.69B ILS

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202517.26B714.00M4.32%
Dec 31, 202416.54B698.00M4.40%
Dec 31, 202315.85B921.00M6.17%
Dec 31, 202214.93B-953.00M-6.00%
Dec 31, 202115.88B-781.00M-4.69%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Danel (Adir Yeoshua) 2.87B
Kamada 578.74M
BrainsWay 162.56M
SofWave Medical 255.13M
Bait Bakfar 107.78M
Ilex Medical 917.10M
Novolog (Pharm-Up 1966) 1.97B
Geffen Residence & Renewal 84.00K
Revenue Rankings

Teva Pharmaceutical Industries News

More News